Filing Details
- Accession Number:
- 0001209191-20-062937
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-11 16:22:33
- Reporting Period:
- 2020-12-09
- Accepted Time:
- 2020-12-11 16:22:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1679082 | Myovant Sciences Ltd. | MYOV | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1712069 | Matthew Lang | C/O Myovant Sciences Inc. 2000 Sierra Point Parkway, 9Th Floor Brisbane CA 94005 | General Counsel & Corp. Secy. | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Acquisiton | 2020-12-09 | 600 | $7.78 | 146,465 | No | 4 | M | Direct | |
| Common Shares | Disposition | 2020-12-09 | 600 | $25.08 | 145,865 | No | 4 | S | Direct | |
| Common Shares | Acquisiton | 2020-12-10 | 19,400 | $7.78 | 165,265 | No | 4 | M | Direct | |
| Common Shares | Disposition | 2020-12-10 | 19,400 | $25.20 | 145,865 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Shares | Stock Option (Right to Buy) | Disposition | 2020-12-09 | 600 | $0.00 | 600 | $7.78 |
| Common Shares | Stock Option (Right to Buy) | Disposition | 2020-12-10 | 19,400 | $0.00 | 19,400 | $7.78 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 279,400 | 2027-07-16 | No | 4 | M | Direct | |
| 260,000 | 2027-07-16 | No | 4 | M | Direct |
Footnotes
- Shares sold pursuant to a 10b5-1 trading plan.
- The shares were sold at prices ranging from $25.07 to $25.09. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The shares were sold at prices ranging from $25.05 to $25.48. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Fully vested.
Billionaire Hedge Funds
